PHENYTOIN Side Effects

7019598-2 | Confusional State, Drooling, Gait Disturbance, Lethargy, Mental Status Changes, Sedation
on Sep 28, 2010 Male patient from UNITED STATES , 78 years of age, weighting 116.0 lb, was diagnosed with convulsion and was treated with Phenytoin (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, drooling, gait disturbance, lethargy, mental status changes, sedation. Phenytoin dosage: 300 Mg Hs Po. Patient was hospitalized.

7013723-5 | Hepatic Adenoma
Patient was taking Phenytoin (View Usage). Patient had the following side effects: hepatic adenoma on Sep 14, 2010 from UNITED STATES Additional patient health information: Female patient , 46 years of age, was diagnosed with convulsion and. Phenytoin dosage: .

6992904-0 | Agitation, Pneumonia Aspiration, Respiratory Acidosis, Status Epilepticus, Treatment Noncompliance, Vomiting
Adverse event was reported on Sep 06, 2010 by a Male patient taking Phenytoin (View Usage) (Dosage: 300 Mg, 1x/day) . Location: SAUDI ARABIA , 28 years of age, After Phenytoin was administered, patient had the following side effects: agitation, pneumonia aspiration, respiratory acidosis, status epilepticus, treatment noncompliance, vomiting. During the same period patient was treated with LEVETIRACETAM (1500 Mg, 2x/day) (View Levetiracetam Review and Levetiracetam Label ), VALPROIC ACID (500 Mg, 2x/day) (View Valproic Acid Review and Valproic Acid Label ). Patient was hospitalized.

6980787-4 | Leukopenia, Mouth Ulceration
on Sep 02, 2010 Male patient from UNITED KINGDOM , 77 years of age, was treated with Phenytoin (View Usage). Patient experienced the following unwanted or unexpected effects: leukopenia, mouth ulceration. Phenytoin dosage: Unk. During the same period patient was treated with WARFARIN (View Warfarin Review and Warfarin Label ).


6979295-6 | Hepatic Adenoma, Tumour Perforation
on Aug 30, 2010 Female patient from UNITED STATES , 46 years of age, was diagnosed with convulsion and was treated with Phenytoin (View Usage). Patient had the following side effects: hepatic adenoma, tumour perforation. Phenytoin dosage: . Patient was hospitalized.

6959672-X | Cerebrovascular Disorder, Linear Iga Disease, Toxic Epidermal Necrolysis
Patient was taking Phenytoin (View Usage). After Phenytoin was administered, patient had the following side effects: cerebrovascular disorder, linear iga disease, toxic epidermal necrolysis on Aug 18, 2010 from IRELAND Additional patient health information: Female patient , 57 years of age, was diagnosed with convulsion and. Phenytoin dosage: . During the same period patient was treated with FUROSEMIDE (CON.) (View Furosemide (con.) Review and Furosemide (con.) Label ), VANCOMYCIN (CON.) (View Vancomycin (con.) Review and Vancomycin (con.) Label ), CIPROFLOXACIN (CON.) (View Ciprofloxacin (con.) Review and Ciprofloxacin (con.) Label ), AMPHOTERICIN (CON.) (View Amphotericin (con.) Review and Amphotericin (con.) Label ), METRONIDAZOLE (CON.) (View Metronidazole (con.) Review and Metronidazole (con.) Label ), AMIODARONE (CON.) (View Amiodarone (con.) Review and Amiodarone (con.) Label ). Patient was hospitalized.

6959338-6 | Product Substitution Issue
Adverse event was reported on Aug 31, 2010 by a Female patient taking Phenytoin (View Usage) (Dosage: Phenytoin 200mg Po) was diagnosed with convulsion and. Location: UNITED STATES , weighting 129.2 lb, Patient experienced the following unwanted or unexpected effects: product substitution issue.

6936176-1 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Albumin Decreased, Blood Bilirubin Increased, Blood Potassium Increased, Blood Sodium Decreased, Bradycardia, Cardiotoxicity
on Aug 05, 2010 Male patient from TAIWAN, PROVINCE OF CHINA , 35 years of age, was diagnosed with epilepsy (What is epilepsy?) and was treated with Phenytoin (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood bilirubin increased, blood potassium increased, blood sodium decreased, bradycardia, cardiotoxicity. Phenytoin dosage: 200 Mg;bid;po. Patient was hospitalized.

6925948-5 | Lip Swelling, Mouth Ulceration, Oropharyngeal Pain, Periorbital Oedema, Rash Erythematous, Rash Pruritic, Stevens-johnson Syndrome
on Aug 04, 2010 Female patient from UNITED KINGDOM , 62 years of age, was diagnosed with convulsion, parkinson's disease (What is parkinson's disease?) and was treated with Phenytoin (View Usage). After Phenytoin was administered, patient had the following side effects: lip swelling, mouth ulceration, oropharyngeal pain, periorbital oedema, rash erythematous, rash pruritic, stevens-johnson syndrome. Phenytoin dosage: 300 Mg, 1x/day. During the same period patient was treated with CITALOPRAM (10 Mg, 1x/day) (View Citalopram Review and Citalopram Label ), LOSARTAN (50 Mg, 1x/day) (View Losartan Review and Losartan Label ), OMEPRAZOLE (20 Mg, 1x/day) (View Omeprazole Review and Omeprazole Label ), RASAGILINE (1 Mg, 1x/day) (View Rasagiline Review and Rasagiline Label ), TOLTERODINE (4 Mg, 1x/day) (View Tolterodine Review and Tolterodine Label ). Patient was hospitalized.

6924166-4 | Blister, Dialysis, Erythema Multiforme, Hepatic Failure, Renal Failure Acute, Respiratory Failure, Skin Exfoliation, Toxic Epidermal Necrolysis
Patient was taking Phenytoin (View Usage). Patient experienced the following unwanted or unexpected effects: blister, dialysis (What is dialysis?), erythema multiforme, hepatic failure, renal failure acute, respiratory failure, skin exfoliation, toxic epidermal necrolysis on Aug 12, 2010 from UNITED STATES Additional patient health information: Female patient , 61 years of age, weighting 181.4 lb, . Phenytoin dosage: . Patient was hospitalized.

6919979-9 | Grand Mal Convulsion
Adverse event was reported on Jul 28, 2010 by a Female patient taking Phenytoin (View Usage) (Dosage: 10 Mg/kg/day) . Location: CHINA , child 9 years of age, Patient had the following side effects: grand mal convulsion.

6912435-3 | Pruritus
on May 30, 2008 Female patient from UNITED STATES , weighting 165.0 lb, was diagnosed with prophylaxis, diabetes mellitus and was treated with Phenytoin (View Usage). After Phenytoin was administered, patient had the following side effects: pruritus. Phenytoin dosage: . During the same period patient was treated with ANTIHYPERTENSIVES (View Antihypertensives Review and Antihypertensives Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

6912179-8 | Convulsion
on Feb 11, 2008 Female patient from UNITED STATES , weighting 95.20 lb, was diagnosed with convulsion and was treated with Phenytoin (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion. Phenytoin dosage: .

6902297-2 | Ataxia, Convulsion, Decreased Appetite, Depressed Mood, Dizziness, Dysstasia
Patient was taking Phenytoin (View Usage). Patient had the following side effects: ataxia (What is ataxia?), convulsion, decreased appetite, depressed mood, dizziness (What is dizziness?), dysstasia on Aug 02, 2010 from UNITED STATES Additional patient health information: Male patient , 66 years of age, weighting 93.70 lb, was diagnosed with convulsion and. Phenytoin dosage: 330 Mg Every Day Po. Patient was hospitalized.

6874706-9 | Pleural Effusion
Adverse event was reported on Jul 06, 2010 by a Female patient taking Phenytoin (View Usage) (Dosage: Many Years) . Location: UNITED STATES , 73 years of age, After Phenytoin was administered, patient had the following side effects: pleural effusion.

6843982-0 | Asthenia, Ataxia, Balance Disorder, Blood Albumin Decreased, Hyperreflexia, Nystagmus, Therapeutic Agent Toxicity, Tremor
on Jul 14, 2010 Female patient from UNITED STATES , 73 years of age, weighting 145.5 lb, was diagnosed with convulsion prophylaxis and was treated with Phenytoin (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, ataxia (What is ataxia?), balance disorder, blood albumin decreased, hyperreflexia, nystagmus, therapeutic agent toxicity, tremor. Phenytoin dosage: 100 Mg/300 Mg Qam Qhs Po. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CALCIUM + VITAMIN D (View Calcium + Vitamin D Review and Calcium + Vitamin D Label ), CYANOCOBALAMIN (View Cyanocobalamin Review and Cyanocobalamin Label ), DILTIAZEM (View Diltiazem Review and Diltiazem Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6843945-5 | Blood Albumin Decreased, Compression Fracture, Fall, Thoracic Vertebral Fracture
on Jul 14, 2010 Female patient from UNITED STATES , 74 years of age, weighting 132.3 lb, was diagnosed with convulsion and was treated with Phenytoin (View Usage). Patient had the following side effects: blood albumin decreased, compression fracture, fall (What is fall?), thoracic vertebral fracture. Phenytoin dosage: 100 Mg Tid Po, Prior To Admit. During the same period patient was treated with MEPROBAMATE (View Meprobamate Review and Meprobamate Label ), ALBUTEROL/IPRATROPIUM NEBULIZER (View Albuterol/ipratropium Nebulizer Review and Albuterol/ipratropium Nebulizer Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), TRAVOPROST (View Travoprost Review and Travoprost Label ), SENNA (View Senna Review and Senna Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ). Patient was hospitalized.

6839782-8 | Anaphylactic Reaction
Patient was taking Phenytoin (View Usage). After Phenytoin was administered, patient had the following side effects: anaphylactic reaction on Jun 24, 2010 from UNITED KINGDOM Additional patient health information: Male patient , child 3 years of age, was diagnosed with status epilepticus and. Phenytoin dosage: 270 Mg Milligram(s),. During the same period patient was treated with CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), (DIAZEP) (View (diazep) Review and (diazep) Label ), (EPILIM) (View (epilim) Review and (epilim) Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), (PARACETAMOL) (View (paracetamol) Review and (paracetamol) Label ), (PARALDEHYDE) (View (paraldehyde) Review and (paraldehyde) Label ).

6814612-9 | Anaphylactic Reaction
Adverse event was reported on Jun 24, 2010 by a Male patient taking Phenytoin (View Usage) (Dosage: 270 Mg, Unk) was diagnosed with status epilepticus and. Location: UNITED KINGDOM , child 3 years of age, weighting 33.07 lb, Patient experienced the following unwanted or unexpected effects: anaphylactic reaction. During the same period patient was treated with CEFTRIAXONE (Unk) (View Ceftriaxone Review and Ceftriaxone Label ), DIAZEPAM (Unk) (View Diazepam Review and Diazepam Label ), EPILIM (Unk) (View Epilim Review and Epilim Label ), LORAZEPAM (Unk) (View Lorazepam Review and Lorazepam Label ), PARACETAMOL (Unk) (View Paracetamol Review and Paracetamol Label ), PARALDEHYDE (Unk) (View Paraldehyde Review and Paraldehyde Label ).

6813617-1 | Overdose, Stupor
on Jun 21, 2010 Female patient from CANADA , 42 years of age, was treated with Phenytoin (View Usage). Patient had the following side effects: overdose, stupor. Phenytoin dosage: 3600 Mg, Unk. Patient was hospitalized.

6791095-9 | Ataxia, Drooling, Dysarthria, Fall, Lethargy, Mental Status Changes, Sedation, Therapeutic Agent Toxicity, Tremor
on Jun 23, 2010 Male patient from UNITED STATES , 33 years of age, weighting 155.0 lb, was diagnosed with convulsion, bipolar disorder (What is bipolar disorder?) and was treated with Phenytoin (View Usage). After Phenytoin was administered, patient had the following side effects: ataxia (What is ataxia?), drooling, dysarthria, fall (What is fall?), lethargy, mental status changes, sedation, therapeutic agent toxicity, tremor. Phenytoin dosage: 200 Mg Tid Po. During the same period patient was treated with LITHIUM CARBONATE (600 Mg Tid Po) (View Lithium Carbonate Review and Lithium Carbonate Label ), DIVALPROEX EXTENDED RELEASE (View Divalproex Extended-release Review and Divalproex Extended-release Label ), QUETIAPINE (View Quetiapine Review and Quetiapine Label ), LORATADINE (View Loratadine Review and Loratadine Label ). Patient was hospitalized.

6781983-1 | Confusional State, Disorientation, Eye Rolling, Headache, Tonic Clonic Movements
Patient was taking Phenytoin (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, disorientation, eye rolling, headache (What is headache?), tonic clonic movements on Jun 18, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 140.0 lb, was diagnosed with epilepsy (What is epilepsy?) and. Phenytoin dosage: 100 Mg Tid.

6754382-6 | Acidosis, Hypoxia, Ischaemia, Priapism, Therapeutic Agent Toxicity
Adverse event was reported on May 24, 2010 by a Male patient taking Phenytoin (View Usage) (Dosage: 500 Mg;) was diagnosed with epilepsy (What is epilepsy?) and. Location: UNITED KINGDOM , 29 years of age, Patient had the following side effects: acidosis, hypoxia, ischaemia, priapism, therapeutic agent toxicity. During the same period patient was treated with TOPIRAMATE (View Topiramate Review and Topiramate Label ). Patient was hospitalized.

6754375-9 | Acute Hepatic Failure, Atrial Fibrillation, Brain Stem Haemorrhage, Cerebral Disorder, Coagulopathy, Gastrointestinal Haemorrhage, Hepatic Encephalopathy, Hepatitis Acute, Hypoglycaemia
on May 18, 2010 Male patient from UNITED KINGDOM , 42 years of age, was treated with Phenytoin (View Usage). After Phenytoin was administered, patient had the following side effects: acute hepatic failure, atrial fibrillation (What is atrial fibrillation?), brain stem haemorrhage, cerebral disorder, coagulopathy, gastrointestinal haemorrhage, hepatic encephalopathy, hepatitis acute, hypoglycaemia. Phenytoin dosage: . During the same period patient was treated with FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ).

6753017-6 | Brain Herniation, Brain Oedema, Hepatic Encephalopathy, Hepatic Necrosis, Hepatitis Acute, Lung Consolidation, Pulmonary Congestion, Pulmonary Oedema
on May 17, 2010 Male patient from UNITED KINGDOM , 42 years of age, was treated with Phenytoin (View Usage). Patient experienced the following unwanted or unexpected effects: brain herniation, brain oedema, hepatic encephalopathy, hepatic necrosis, hepatitis acute, lung consolidation, pulmonary congestion, pulmonary oedema. Phenytoin dosage: . During the same period patient was treated with FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ).

6748518-0 | Product Substitution Issue
Patient was taking Phenytoin (View Usage). Patient had the following side effects: product substitution issue on May 27, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 151.0 lb, was diagnosed with convulsion and. Phenytoin dosage: 2 Tablets Twice Daily Po.

6737649-7 | Dizziness, Fall, Hyponatraemia
Adverse event was reported on May 21, 2010 by a Female patient taking Phenytoin (View Usage) (Dosage: 200 Mg Bid Po) was diagnosed with convulsion and. Location: UNITED STATES , 85 years of age, weighting 138.9 lb, After Phenytoin was administered, patient had the following side effects: dizziness (What is dizziness?), fall (What is fall?), hyponatraemia. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), CALCITRIOL (View Calcitriol Review and Calcitriol Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6734114-8 | Hypocalcaemia
on May 07, 2010 Male patient from UNITED STATES , 57 years of age, was diagnosed with status epilepticus and was treated with Phenytoin (View Usage). Patient experienced the following unwanted or unexpected effects: hypocalcaemia. Phenytoin dosage: 1 G Gram(s). During the same period patient was treated with LORAZEPAM (View Lorazepam Review and Lorazepam Label ), LEVETIRACETAM (View Levetiracetam Review and Levetiracetam Label ), VALPROIC ACID (View Valproic Acid Review and Valproic Acid Label ). Patient was hospitalized.

6731624-4 | Coma
on May 18, 2010 Female patient from UNITED STATES , 86 years of age, was diagnosed with convulsion and was treated with Phenytoin (View Usage). Patient had the following side effects: coma. Phenytoin dosage: 100mg Tid Po. During the same period patient was treated with FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), LASIX (View Lasix Review and Lasix Label ), NOVOLIN (View Novolin Review and Novolin Label ), PLAVIX (View Plavix Review and Plavix Label ), K DUR (View K-dur Review and K-dur Label ), ZANTAC (View Zantac Review and Zantac Label ), VIT B1 (View Vit B1 Review and Vit B1 Label ), VIT D (View Vit D Review and Vit D Label ). Patient was hospitalized.

6725233-0 | Convulsion, Product Substitution Issue
Patient was taking Phenytoin (View Usage). After Phenytoin was administered, patient had the following side effects: convulsion, product substitution issue on May 13, 2010 from UNITED STATES Additional patient health information: Male patient , 53 years of age, was diagnosed with convulsion and. Phenytoin dosage: 500mg Qhs. Patient was hospitalized.

6720705-7 | Biliary Tract Disorder, Brain Abscess, Brain Herniation, Brain Oedema, Hepatic Congestion, Hepatic Encephalopathy, Hepatic Failure, Hepatic Necrosis, Hepatitis Acute
Adverse event was reported on Apr 29, 2010 by a Male patient taking Phenytoin (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 42 years of age, Patient experienced the following unwanted or unexpected effects: biliary tract disorder, brain abscess, brain herniation, brain oedema, hepatic congestion, hepatic encephalopathy, hepatic failure, hepatic necrosis, hepatitis acute. During the same period patient was treated with FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ).

6720122-X | Cerebellar Syndrome, Condition Aggravated, Diplopia, Fall, Hypothyroidism, Mean Cell Volume Increased, Therapeutic Agent Toxicity
on Apr 21, 2010 Female patient from NEW ZEALAND , 48 years of age, was diagnosed with epilepsy (What is epilepsy?), hypothyroidism and was treated with Phenytoin (View Usage). Patient had the following side effects: cerebellar syndrome, condition aggravated, diplopia, fall (What is fall?), hypothyroidism, mean cell volume increased, therapeutic agent toxicity. Phenytoin dosage: 400 Mg, Daily, Oral. During the same period patient was treated with THYROXINE, STRENGTH AND MANUFACTURER UNK (200 Mcg, Once Daily, Oral) (View Thyroxine, Strength And Manufacturer Unk Review and Thyroxine, Strength And Manufacturer Unk Label ), CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ). Patient was hospitalized.

6717700-0 | Body Temperature Increased, Confusional State, Cytokine Storm, Deep Vein Thrombosis, Delirium, Dermatitis Allergic, Impetigo, Petechiae
on Apr 28, 2010 Male patient from UNITED KINGDOM , 45 years of age, weighting 200.6 lb, was treated with Phenytoin (View Usage). After Phenytoin was administered, patient had the following side effects: body temperature increased, confusional state, cytokine storm, deep vein thrombosis (What is deep vein thrombosis?), delirium, dermatitis allergic, impetigo (What is impetigo?), petechiae. Phenytoin dosage: 50 Mg, Unk. During the same period patient was treated with AVASTIN (1287.5 Mg, Every 3 Weeks) (View Avastin Review and Avastin Label ), NEULASTA (6 Mg, Every 3 Weeks) (View Neulasta Review and Neulasta Label ), NEUPOGEN (Unk) (View Neupogen Review and Neupogen Label ), CARBOPLATIN (50 Mg, Every 3 Weeks) (View Carboplatin Review and Carboplatin Label ), DEXAMETHASONE (6 Mg, Unk) (View Dexamethasone Review and Dexamethasone Label ), METOCLOPRAMIDE (10 Mg, Unk) (View Metoclopramide Review and Metoclopramide Label ), ONDANSETRON (8 Mg, 2x/day) (View Ondansetron Review and Ondansetron Label ), VALPROATE SODIUM (Unk) (View Valproate Sodium Review and Valproate Sodium Label ). Patient was hospitalized.

6701001-0 | Body Temperature Increased, Confusional State, Cytokine Storm, Deep Vein Thrombosis, Delirium, Dermatitis Allergic, Impetigo, Petechiae
Patient was taking Phenytoin (View Usage). Patient experienced the following unwanted or unexpected effects: body temperature increased, confusional state, cytokine storm, deep vein thrombosis (What is deep vein thrombosis?), delirium, dermatitis allergic, impetigo (What is impetigo?), petechiae on Apr 19, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 45 years of age, weighting 200.6 lb, was diagnosed with glioblastoma multiforme, vomiting and. Phenytoin dosage: 50 Mg, Unk. During the same period patient was treated with AVASTIN (1287.5 Mg, Every 3 Weeks) (View Avastin Review and Avastin Label ), NEULASTA (6 Mg, Every 3 Weeks) (View Neulasta Review and Neulasta Label ), NEUPOGEN (Unk) (View Neupogen Review and Neupogen Label ), CARBOPLATIN (50 Mg, Every 3 Weeks) (View Carboplatin Review and Carboplatin Label ), DEXAMETHASONE (6 Mg, 1x/day) (View Dexamethasone Review and Dexamethasone Label ), METOCLOPRAMIDE (10 Mg, 3 As Needed) (View Metoclopramide Review and Metoclopramide Label ), ONDANSETRON (16 Mg, Twice Weekly) (View Ondansetron Review and Ondansetron Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ). Patient was hospitalized.

6699216-3 | Body Temperature Increased, Confusional State, Cytokine Storm, Deep Vein Thrombosis, Delirium, Dermatitis Allergic, Impetigo, Petechiae
Adverse event was reported on Apr 16, 2010 by a Male patient taking Phenytoin (View Usage) (Dosage: ) was diagnosed with glioblastoma multiforme and. Location: UNITED KINGDOM , 45 years of age, weighting 200.6 lb, Patient had the following side effects: body temperature increased, confusional state, cytokine storm, deep vein thrombosis (What is deep vein thrombosis?), delirium, dermatitis allergic, impetigo (What is impetigo?), petechiae. During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), PEGFILGRASTIM (View Pegfilgrastim Review and Pegfilgrastim Label ). Patient was hospitalized.

6695941-9 | Body Temperature Increased, Confusional State, Cytokine Storm, Deep Vein Thrombosis, Delirium, Dermatitis Allergic, Impetigo, Petechiae
on Apr 14, 2010 Male patient from UNITED KINGDOM , 45 years of age, weighting 200.6 lb, was diagnosed with glioblastoma multiforme, vomiting and was treated with Phenytoin (View Usage). After Phenytoin was administered, patient had the following side effects: body temperature increased, confusional state, cytokine storm, deep vein thrombosis (What is deep vein thrombosis?), delirium, dermatitis allergic, impetigo (What is impetigo?), petechiae. Phenytoin dosage: 50 Mg, Unk. During the same period patient was treated with AVASTIN (1287.5 Mg, Every 3 Weeks) (View Avastin Review and Avastin Label ), NEULASTA (6 Mg, Every 3 Weeks) (View Neulasta Review and Neulasta Label ), NEUPOGEN (Unk) (View Neupogen Review and Neupogen Label ), CARBOPLATIN (50 Mg, Every 3 Weeks) (View Carboplatin Review and Carboplatin Label ), DEXAMETHASONE (6 Mg, 1x/day) (View Dexamethasone Review and Dexamethasone Label ), METOCLOPRAMIDE (10 Mg, 3 As Needed) (View Metoclopramide Review and Metoclopramide Label ), ONDANSETRON (16 Mg, Twice Weekly) (View Ondansetron Review and Ondansetron Label ), VALPROATE SODIUM (View Valproate Sodium Review and Valproate Sodium Label ). Patient was hospitalized.

6694489-5 | Body Temperature Increased, Confusional State, Cytokine Storm, Deep Vein Thrombosis, Delirium, Dermatitis Allergic, Impetigo, Petechiae
on Apr 12, 2010 Male patient from UNITED KINGDOM , 45 years of age, weighting 200.6 lb, was treated with Phenytoin (View Usage). Patient experienced the following unwanted or unexpected effects: body temperature increased, confusional state, cytokine storm, deep vein thrombosis (What is deep vein thrombosis?), delirium, dermatitis allergic, impetigo (What is impetigo?), petechiae. Phenytoin dosage: 50 Mg, Unk. During the same period patient was treated with AVASTIN (1287.5 Mg, Cyclic) (View Avastin Review and Avastin Label ), NEULASTA (6 Mg, Every 3 Weeks) (View Neulasta Review and Neulasta Label ), NEUPOGEN (Unk) (View Neupogen Review and Neupogen Label ), CARBOPLATIN (50 Mg, Every 3 Weeks) (View Carboplatin Review and Carboplatin Label ), DEXAMETHASONE (6 Mg, Unk) (View Dexamethasone Review and Dexamethasone Label ), METOCLOPRAMIDE (10 Mg, Unk) (View Metoclopramide Review and Metoclopramide Label ), ONDANSETRON (8 Mg, 2x/day) (View Ondansetron Review and Ondansetron Label ), VALPROATE SODIUM (Unk) (View Valproate Sodium Review and Valproate Sodium Label ). Patient was hospitalized.

6688210-4 | Body Temperature Increased, Confusional State, Cytokine Storm, Deep Vein Thrombosis, Delirium, Dermatitis Allergic, Impetigo, Petechiae
Patient was taking Phenytoin (View Usage). Patient had the following side effects: body temperature increased, confusional state, cytokine storm, deep vein thrombosis (What is deep vein thrombosis?), delirium, dermatitis allergic, impetigo (What is impetigo?), petechiae on Apr 12, 2010 from UNITED KINGDOM Additional patient health information: Male patient , 45 years of age, weighting 200.6 lb, was diagnosed with glioblastoma multiforme and. Phenytoin dosage: . During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), PEGFILGRASTIM (View Pegfilgrastim Review and Pegfilgrastim Label ). Patient was hospitalized.

6669619-1 | Interstitial Lung Disease, Systemic Lupus Erythematosus
Adverse event was reported on Feb 23, 2010 by a Female patient taking Phenytoin (View Usage) (Dosage: 300 Mg/day) was diagnosed with epilepsy (What is epilepsy?) and. Location: JAPAN , 48 years of age, weighting 125.7 lb, After Phenytoin was administered, patient had the following side effects: interstitial lung disease, systemic lupus erythematosus. During the same period patient was treated with CARBAMAZEPINE (500 Mg/day) (View Carbamazepine Review and Carbamazepine Label ). Patient was hospitalized.

6668666-3 | Acute Hepatic Failure, Brain Herniation, Hepatic Encephalopathy, Hepatitis Acute
on Mar 19, 2010 Male patient from UNITED KINGDOM , 42 years of age, was treated with Phenytoin (View Usage). Patient experienced the following unwanted or unexpected effects: acute hepatic failure, brain herniation, hepatic encephalopathy, hepatitis acute. Phenytoin dosage: . During the same period patient was treated with CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ).

6668660-2 | Brain Herniation, Brain Oedema, Hepatic Encephalopathy, Hepatic Failure, Hepatitis Acute
on Mar 18, 2010 Male patient from UNITED KINGDOM , 42 years of age, was treated with Phenytoin (View Usage). Patient had the following side effects: brain herniation, brain oedema, hepatic encephalopathy, hepatic failure, hepatitis acute. Phenytoin dosage: 125 Mg/ 2ml. During the same period patient was treated with FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ).

6667234-7 | Interstitial Lung Disease, Systemic Lupus Erythematosus
Patient was taking Phenytoin (View Usage). After Phenytoin was administered, patient had the following side effects: interstitial lung disease, systemic lupus erythematosus on Feb 23, 2010 from JAPAN Additional patient health information: Female patient , 48 years of age, weighting 125.7 lb, was diagnosed with epilepsy (What is epilepsy?) and. Phenytoin dosage: 300 Mg/day. During the same period patient was treated with CARBAMAZEPINE (500 Mg/day) (View Carbamazepine Review and Carbamazepine Label ). Patient was hospitalized.

6656449-X | Foetal Anticonvulsant Syndrome
Adverse event was reported on Mar 15, 2010 by a Male patient taking Phenytoin (View Usage) (Dosage: ) was diagnosed with convulsion and. Location: NEPAL , weighting 6.61 lb, Patient experienced the following unwanted or unexpected effects: foetal anticonvulsant syndrome. During the same period patient was treated with CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ).

6649732-5 | Haemorrhage
on Mar 24, 2010 Male patient from UNITED STATES , 42 years of age, weighting 230.5 lb, was treated with Phenytoin (View Usage). Patient had the following side effects: haemorrhage. Phenytoin dosage: Iv.

6638427-X | Abdominal Pain, Coagulopathy, Diarrhoea, Headache, Jaundice, Malaise, Mental Status Changes, Rash
on Mar 16, 2010 Female patient from UNITED STATES , 35 years of age, weighting 183.0 lb, was diagnosed with convulsion and was treated with Phenytoin (View Usage). After Phenytoin was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), coagulopathy, diarrhoea, headache (What is headache?), jaundice (What is jaundice?), malaise, mental status changes, rash (What is rash?). Phenytoin dosage: 200 Mg Daily Oral 047. During the same period patient was treated with KAVA KAVA (100 Mg Daily Oral 047) (View Kava Kava Review and Kava Kava Label ). Patient was hospitalized.

6635574-3 | Anxiety, Confusional State, Coordination Abnormal, Hallucination
Patient was taking Phenytoin (View Usage). Patient experienced the following unwanted or unexpected effects: anxiety (What is anxiety?), confusional state, coordination abnormal, hallucination on Mar 11, 2010 from UNITED STATES Additional patient health information: Male patient , 30 years of age, weighting 209.0 lb, was diagnosed with convulsion and. Phenytoin dosage: 4 Nightly. Patient was hospitalized.

6632355-1 | Dizziness
Adverse event was reported on Mar 01, 2010 by a Female patient taking Phenytoin (View Usage) (Dosage: 700 Mg;qd;po) was diagnosed with epilepsy (What is epilepsy?) and. Location: UNITED STATES , 57 years of age, Patient had the following side effects: dizziness (What is dizziness?). Patient was hospitalized.

6622186-0 | Interstitial Lung Disease, Systemic Lupus Erythematosus
on Feb 23, 2010 Female patient from JAPAN , 48 years of age, weighting 125.7 lb, was diagnosed with epilepsy (What is epilepsy?) and was treated with Phenytoin (View Usage). After Phenytoin was administered, patient had the following side effects: interstitial lung disease, systemic lupus erythematosus. Phenytoin dosage: 300 Mg/day. During the same period patient was treated with CARBAMAZEPINE (500 Mg/day) (View Carbamazepine Review and Carbamazepine Label ). Patient was hospitalized.

6614713-4 | Completed Suicide
on Feb 19, 2010 Male patient from UNITED STATES , 56 years of age, was treated with Phenytoin (View Usage). Patient experienced the following unwanted or unexpected effects: completed suicide. Phenytoin dosage: . During the same period patient was treated with QUETIAPINE (View Quetiapine Review and Quetiapine Label ), PHENOBARBITAL TAB (View Phenobarbital Tab Review and Phenobarbital Tab Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ), ESCITALOPRAM (View Escitalopram Review and Escitalopram Label ), EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE (View Emtricitabine/tenofovir Disoproxil Fumarate Review and Emtricitabine/tenofovir Disoproxil Fumarate Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ), METHYLPHENIDATE (View Methylphenidate Review and Methylphenidate Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ).

6608995-2 | Abdominal Pain, Coagulopathy, Jaundice, Malaise, Mental Status Changes, Pyrexia
Patient was taking Phenytoin (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), coagulopathy, jaundice (What is jaundice?), malaise, mental status changes, pyrexia on Feb 26, 2010 from UNITED STATES Additional patient health information: Female patient , 67 years of age, weighting 218.3 lb, was diagnosed with epilepsy (What is epilepsy?) and. Phenytoin dosage: 300 Mg Daily Oral 047. Patient was hospitalized.